CAS: 4714-62-9; 4-(Methylamino)Benzonitrile

该化合物是一种有机化合物,其特性为:以甲基氨基组取代苯硝基核,这一结构使其成为制药和农用化学合成的宝贵中间体,特别是在开发活性成分和精细化学物方面.其硝酸能为进一步衍生提供回活动,而甲基氨基组则增强目标分子的溶解性和结合特性.该化合物的特点是高度纯度和稳定性,确保合成应用的一贯性.该化合物在热循环化学以及染料和颜料的建筑材料中的用途进一步凸显了其在工业和研究环境中的多变性.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

N-methyl-N-(4-cyanophenyl)nitrous amide N-(4-cyanophenyl)-N-methylacetamide styrene 4-cyano-N,N-dimethylaniline-N-oxide 4-methylamino-benzamidine N-(4-cyanophenyl)-N-methylcarbamoyl chloride N-(4-cyanophenyl)-N-methylformamide p-cyano-N-methylaniline ethyl carbamate

合成工艺路线路线简述

  • 合成目标产物 4-(N-Methylamino)Benzonitrile 主要起始原料 4-Aminobenzonitrile
  • (文献来源)合成步骤主要原料 4-Aminobenzonitrile
对氨基苯腈置于甲醇,Sodium Tetrahydroborate,Sodium Methylate体系中,用 甲醇 作为反应溶剂,化学反应 18.0H,反应生成 N-甲基-4-氰基苯胺
参考文献:Direct Condensation Of Functionalized Sp3 Carbons With Formanilides For Enamine Synthesis Using An In Situ Generated Hmds Amide Catalyst
标题:Direct Condensation Of Functionalized Sp3 Carbons With Formanilides For Enamine Synthesis Using An In Situ Generated Hmds Amide Catalyst
摘要:使用在场反应生成的hmds酰胺碱通过氨基硅烷和氟化盐的组合合成了包括β-烯胺酯在内的官能化恩酰胺.
DOI:10.1039/c4Cc02228A

海关参考信息

专利信息


专利号:US-9533971-B2
优先权日:2012-10-29
标 题 :Process for the synthesis of dabigatran and its intermediates
发明人:PULLAGURLA MANIK REDDY; RANGISETTY JAGADEESH BABU; NANDAKUMAR MECHERIL VALSAN
权利人:BIOPHORE INDIA PHARMACEUTICALS PVT LTD; BIOPHORE INDIA PHARMACEUTICALS PVT LTD
摘要:The present invention describes an improved process for the preparation of Dabigatran Etexilate (Formula-VII) or it's pharmaceutically acceptable salt for the treatment of thrombosis, cardiovascular diseases etc. and intermediates involved in the synthesis.

专利号:US-9676783-B2
优先权日:2008-10-22
标 题:Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds
发明人:HAAS JULIA; ANDREWS STEVEN W; JIANG YUTONG; ZHANG GAN
权利人:ARRAY BIOPHARMA INC
摘要:Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.

专利号:US-8846898-B2
优先权日:2000-10-17
标题:Phosphinoamidite carboxylates and analogs thereof in the synthesis of oligonucleotide having reduced internucleotide charge
发明人:DELLINGER DOUGLAS J
权利人:DELLINGER DOUGLAS J; Lieure Cornu LLC
摘要:Nucleoside phosphinoamidite carboxylates and analogs are provided that have the structure of formula (III) n nwherein A is hydrogen, hydroxyl, lower alkoxy, lower alkoxy-substituted lower alkoxy, halogen, SH, NH 2 , azide or DL wherein D is O, S or NH and L is a heteroatom-protecting group, unsubstituted hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; B is a nucleobase; and one of R 11 and R 12 is a blocking group and the other is (IV) or (VI)n n nin which W, X, Y, Z, R 1 and n are as defined herein.

专利号:US-2010311960-A1
优先权日:2000-10-17
标 题 :Phosphinoamidite Carboxylates and Analogs Thereof in the Synthesis of Oligonucleotide Having Reduced Internucleotide Charge

专利号:US-2006293511-A1
优先权日:2000-10-17
标 题:Phosphinoamidite carboxylates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge

专利号:US-2015246900-A1
优先权日:2012-10-29
标题 :Process for the Synthesis of Dabigatran and Its Intermediates
山东西亚化学有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.xiyashiji.com
企业联系电话:400-990-3999👤
📞山东西亚化学有限公司 ⚠️参考联系方式
联系人:徐雪
电话:400-990-3999
手机:13395398332
传真:0539-6365991
邮箱:3007715518@qq.com
通信地址: 临沭经济开发区化工园区(厂址)
邮编: 276000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:临沭经济开发区化工园区(厂址)
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Hay, M. B.; Hicks, J. D., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 2, 132.
摘要:Shen, Q.; Guo, F.; Hartwig, J. F., Science of Synthesis: Cross Coupling and Heck-Type Reactions, (2012) 2, 184.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知